WJ
WILSON JAMES N
Director
BoardM
Insider track record
Board DirectorAcross 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by WILSON JAMES N, Director. Officer active across 1 company, notably CORCEPT THERAPEUTICS INC. Cumulatively, 16 disclosures have been published. Breakdown: 0 buy · 4 sells. History available since 21 January 2021. The latest transaction was filed on 27 May 2026 (Don). Regulator: SEC (Form 4). All data is free.
Declarations16 total
4,177 sharesCommon StockSEC:0001193125-26-275964:0
5,823 sharesCommon StockSEC:0001193125-26-275964:1
892,056 shares0Common StockSEC:0001193125-26-248953:0
9,011 shares0Common StockSEC:0001193125-26-248953:1
9,011 shares0Common StockSEC:0001193125-26-248953:2
7,800 shares0Common StockSEC:0000950170-25-010499:0
250,000 shares@ US$3.2956.9% of flowCommon StockSEC:0000950170-25-008963:0
7,800 shares0Common StockSEC:0000950170-24-141638:0
2,000 shares0Common StockSEC:0000950170-24-065537:0
3,000 shares0Common StockSEC:0000950170-23-064309:0
300,000 shares@ US$2.080.0099% mcap100.0% of flowCommon StockSEC:0000899243-22-022855:0
12,000 shares0Common StockSEC:0000899243-22-020700:0
1,188 sharesCommon stockSEC:0001209191-16-089687:0
1,188 sharesCommon stockSEC:0001209191-16-089687:1
7,000 sharesCommon stockSEC:0001209191-16-089687:2
0Common stockSEC:0001209191-16-089687:3
About WILSON JAMES N
James N. Wilson is a Board Member at Corcept Therapeutics Inc. He brings valuable expertise in biotechnology and research. His role involves overseeing the company's strategies and ensuring compliance with industry standards. James contributes to strategic decision-making that influences innovation and growth at Corcept.